Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: Is there a preferred regimen?

被引：24
|
作者：
Einhorn, LH [1 ]
Foster, RS
机构：
[1] Indiana Univ, Dept Med, Indianapolis, IN 46204 USA
[2] Indiana Univ, Dept Urol, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 16期
关键词：
D O I：
10.1200/JCO.2006.05.6184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2597 / 2598
页数：2
相关论文
共 50 条
  • [21] A RANDOMIZED TRIAL OF ETOPOSIDE + CISPLATIN VERSUS VINBLASTINE + BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN IN PATIENTS WITH GOOD-PROGNOSIS GERM-CELL TUMORS
    BOSL, GJ
    GELLER, NL
    BAJORIN, D
    LEITNER, SP
    YAGODA, A
    GOLBEY, RB
    SCHER, H
    VOGELZANG, NJ
    AUMAN, J
    CAREY, R
    FAIR, WR
    HERR, H
    MORSE, M
    SOGANI, P
    WHITMORE, W
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) : 1231 - 1238
  • [22] CISPLATIN, VINBLASTINE, AND BLEOMYCIN VERSUS VINBLASTINE, CISPLATIN, AND ETOPOSIDE IN THE TREATMENT OF ADVANCED GERM-CELL TUMORS OF THE TESTIS - REPLY
    WOZNIAK, AJ
    CUMMINGS, G
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (06) : 1093 - 1094
  • [23] THE TREATMENT OF METASTATIC GERM-CELL TESTICULAR-TUMORS WITH BLEOMYCIN, ETOPOSIDE AND CISPLATIN (BEP)
    PECKHAM, MJ
    BARRETT, A
    LIEW, KH
    HORWICH, A
    ROBINSON, B
    DOBBS, HJ
    MCELWAIN, TJ
    HENDRY, WF
    BRITISH JOURNAL OF CANCER, 1983, 47 (05) : 613 - 619
  • [24] Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors
    Nakagawa, Ryunosuke
    Iwamoto, Hiroaki
    Makino, Tomoyuki
    Kadomoto, Suguru
    Yaegashi, Hiroshi
    Iijima, Masashi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Kadono, Yoshifumi
    Mizokami, Atsushi
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [25] ALTERNATING CYCLES OF ETOPOSIDE PLUS CISPLATIN AND VAB-6 IN THE TREATMENT OF POOR-RISK PATIENTS WITH GERM-CELL TUMORS
    BOSL, GJ
    GELLER, NL
    VOGELZANG, NJ
    CAREY, R
    AUMAN, J
    WHITMORE, WF
    HERR, H
    MORSE, M
    SOGANI, P
    CHAN, E
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) : 436 - 440
  • [26] TREATMENT OF POOR-RISK GERM-CELL TUMORS WITH HIGH-DOSE CISPLATIN AND ETOPOSIDE COMBINED WITH BLEOMYCIN
    DAUGAARD, G
    RORTH, M
    ANNALS OF ONCOLOGY, 1992, 3 (04) : 277 - 282
  • [27] Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin
    Lauritsen, Jakob
    Kier, Maria Gry Gundgaard
    Bandak, Mikkel
    Mortensen, Mette Sakso
    Thomsen, Frederik Birkebaek
    Mortensen, Jann
    Daugaard, Gedske
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1492 - +
  • [28] FOUR CYCLES OF CISPLATIN/ETOPOSIDE/IFOSFAMIDE ARE POSSIBLY SUFFICIENT TO TREAT HIGH-RISK GERM CELL PEDIATRIC PATIENTS. THE BRAZILIAN EXPERIENCE
    Lopes, Luiz Fernando
    Riheiro, Karina C. B.
    Macedo, Carla R. D.
    Pontes, Elitania M.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 750 - 750
  • [29] Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indiana University experience
    Saxman, SB
    Finch, D
    Gonin, R
    Einhorn, LH
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 702 - 706
  • [30] Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer
    Mezvrishvili, Zaza
    Managadze, Laurent
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (3-4) : 621 - 624
12345